Plain-English translation of NCT06334705 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The EGEA4 study is a 30-year follow-up of people previously enrolled in asthma research. Researchers want to learn whether people with asthma have higher risk of heart disease and stroke, and whether shared risk factors (like lifestyle, weight, genetics, or inflammation) explain this connection.
Heart disease and stroke are leading causes of death worldwide, and recent evidence suggests people with asthma may face higher heart disease risk. However, doctors don't yet understand why this happens — whether asthma itself causes heart problems, or whether asthma and heart disease share common underlying causes.
You likely qualify if…
You likely don't qualify if…
You will be invited to complete health checkups and provide information about your medical history and current health. You can choose which examinations you wish to participate in. The study builds on earlier surveys you completed, tracking your heart and overall health over the past 30 years.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
APHP, Hospices Civils de Lyon
Enrollment target
~1,000 participants
Started
February 2024
Primary completion
February 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Valérie Siroux, PHD
Institut National de la Santé Et de la Recherche Médicale, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.